Dr. John Ransom
Raised in the bucolic farm and woods country of northern Delaware, Dr. Ransom developed an early appreciation and respect for the natural world and for all aspects of the biological sciences. He obtained a B.A. in Biology and Psychology from the University of Delaware, and then earned a Ph.D. in Physiology from the UT Southwestern Medical Center. He pursued post-doctoral studies in Immunology at National Jewish Health, where he and co-founder Bill Golde first met and compared notes on the importance of reliable tools to generate the accurate biological results. He continued to study Immunology at the DNAX Research Institute, followed by an engaging period in pharmaceutical discovery and development at Syntex Research. His career then continued as Vice President at several biotechnology companies, some of which he co-founded. Most recently he was the VP of R&D and Head of Emerging Technologies at BioLegend, Inc, a successful biological reagents company. Currently he is co-founder and Chief Scientific Officer of Vivreon Biosciences, LLC, where they aggressively pursue cures for neurodegenerative diseases and other chronic inflammatory conditions.